Form 4 for IDXX Idexx Laboratories
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0000874716-25-000150 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-01 | IDXX | Smith Martin Alexander | EVP | F - Tax | $647.09 | -5 | 1,434 | -0.3% | -$3,235 |
| D | 2025-09-03 | 2025-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | $0.00 | +18 | 1,439 | +1% | $0 |
| D | 2025-09-03 | 2025-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | — | -18 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-01 | F | D | 5 | $647.09 | 1,433.66 | D | — | — | (F2) Closing price of Issuer common stock on the Nasdaq Global Select Market on August 29, 2025. |
| 2 | Common | Common Stock | 2025-09-01 | M | A | 18 | $0.00 | 1,438.66 | D | — | — | (F1) Includes a total of 28.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025. |
| 3 | Derivative | Restricted Stock Unit | 2025-09-01 | M | D | 18 | — | 0 | D | — · — to — | 18 Common Stock | (F4) Not applicable. (F3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022. |